<i>Pseudomonas aeruginosa</i>infection in cystic fibrosis: pathophysiological mechanisms and therapeutic approachesHelena Lund‐Palau, Jane C. Davies, Eric W.F.W. Alton et al.|Expert Review of Respiratory Medicine|2016Cited by 170
Current and future therapies for Pseudomonas aeruginosa infection in patients with cystic fibrosisWynne D. Smith, Jane C. Davies, Emmanuelle Bardin et al.|FEMS Microbiology Letters|2017Cited by 107
Metabolic Phenotyping and Strain Characterisation of Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients Using Rapid Evaporative Ionisation Mass SpectrometryEmmanuelle Bardin, Zoltán Takáts, Simon J. S. Cameron et al.|Scientific Reports|2018Cited by 33
Clinical Expert Panel on Monitoring Potential Lung Toxicity of Inhaled Oligonucleotides: Consensus Points and RecommendationsEric W.F.W. Alton, Homer A. Boushey, Holger Garn et al.|Nucleic Acid Therapeutics|2012Cited by 25